Discover how food brands can adapt to the rising GLP-1 trend. As weight-loss drugs reshape consumer habits, learn which ...

A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.

Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery.

Milestone enables phase-appropriate cGMP testing for early- to late-stage development and commercial release of advanced ...

The researchers first tested their hypothesis by delivering ODN directly to the hindbrain of rats. Once treated, the rats ...

The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite, has successfully completed its Phase I trial.

Appetite suppression will always be at its highest on days one to three after injecting Mounjaro and by days six to seven, ...

Eight weeks. That’s how long it takes, on average, for the pounds to begin creeping back after someone stops taking the world ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance ...

Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for high-impact drug discovery ...

Hydrafacial, the flagship brand belonging to The Beauty Health Company, has released its latest innovation, the Hydrafacial ...

The world of prior authorization, and the hoops we need to jump through, has gotten just more and more ridiculous, bordering ...